US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist

1.138
+0.048+4.36%

Trading May 2 13:08 ET

199.52MMarket Cap-8125P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

92.21%-5.74M

71.52%-6.24M

89.78%-1.36M

145.93%5.93M

84.11%-4.07M

-1,354.81%-73.76M

-14.79%-21.91M

-29.17%-13.3M

-123.38%-12.91M

-28.47%-25.64M

Net income from continuing operations

57.16%-25.09M

-47.39%737K

70.10%-5.69M

51.08%-6.6M

50.68%-13.54M

-226.97%-58.57M

106.19%1.4M

9.14%-19.04M

2.38%-13.49M

-169.48%-27.45M

Operating gains losses

292.75%266K

-133.64%-110K

89.62%-22K

--51K

--347K

---138K

--327K

---212K

----

Depreciation and amortization

24.05%1.24M

3.17%293K

21.67%292K

24.89%296K

50.63%357K

-14.11%998K

-29.70%284K

-8.05%240K

-8.14%237K

-0.84%237K

Other non cash items

----

-78.27%682K

--0

1,036.67%682K

Change In working capital

132.76%9.52M

68.25%-8.83M

-25.64%2.23M

636.95%10.06M

358.65%6.07M

-398.92%-29.05M

-21,467.44%-27.82M

-58.62%2.99M

-102.88%-1.87M

96.25%-2.35M

-Change in receivables

139.32%9.77M

71.75%-7M

-263.00%-2.73M

536.52%8.55M

4,621.55%10.95M

-5,059.68%-24.85M

-5,054.89%-24.8M

-29.74%1.67M

-101.57%-1.96M

100.18%232K

-Change in inventory

149.31%1.17M

227.63%2.53M

132.04%281K

-48.07%309K

-1,640.18%-1.95M

51.24%-2.38M

-540.67%-1.98M

-425.15%-877K

421.93%595K

97.88%-112K

-Change in prepaid assets

335.89%2M

-54.42%-3.25M

9.54%1.95M

96.48%2.9M

119.57%392K

-112.77%-847K

-42.03%-2.1M

164.39%1.78M

-11.35%1.48M

-134.69%-2M

-Change in payables and accrued expense

-302.48%-5.71M

-155.96%-2.79M

308.96%2.7M

27.59%-2.25M

-250.99%-3.37M

-48.82%2.82M

608.97%4.99M

-123.48%-1.29M

-226.34%-3.11M

15.41%2.23M

-Change in other current assets

-86.12%1.13M

-86.96%118K

-101.15%-25K

-94.59%127K

-66.24%905K

0.81%8.11M

-56.53%905K

9.97%2.17M

17.28%2.35M

35.27%2.68M

-Change in other current liabilities

83.41%-2.17M

97.25%-162K

12.98%-2.17M

90.01%-234K

116.90%398K

-51.77%-13.08M

-163.25%-5.89M

-14.17%-2.5M

96.10%-2.34M

-104.22%-2.36M

-Change in other working capital

182.87%3.34M

64.35%1.72M

8.91%2.21M

-41.02%660K

58.23%-1.26M

-53.33%1.18M

-58.34%1.05M

311.89%2.03M

144.44%1.12M

-186.69%-3.02M

Cash from discontinued investing activities

Operating cash flow

92.21%-5.74M

71.52%-6.24M

89.78%-1.36M

145.93%5.93M

84.11%-4.07M

-1,354.81%-73.76M

-14.79%-21.91M

-29.17%-13.3M

-123.38%-12.91M

-28.47%-25.64M

Investing cash flow

Cash flow from continuing investing activities

-105.90%-4.3M

-136.96%-6.87M

-111.19%-1.17M

-85.92%2.97M

-96.57%777K

190.93%72.78M

186.65%18.6M

123.55%10.46M

142.48%21.1M

200.44%22.63M

Net PPE purchase and sale

-41.53%259K

-60.29%110K

-75.56%22K

--0

156.70%127K

170.65%443K

--277K

--90K

--300K

---224K

Net intangibles purchase and sale

---15M

--0

---15M

--0

Net investment purchase and sale

-85.56%10.44M

-138.12%-6.98M

-111.50%-1.19M

-85.72%2.97M

-31.52%15.65M

191.09%72.33M

183.30%18.32M

123.44%10.37M

142.22%20.8M

200.58%22.85M

Cash from discontinued investing activities

Investing cash flow

-105.90%-4.3M

-136.96%-6.87M

-111.19%-1.17M

-85.92%2.97M

-96.57%777K

190.93%72.78M

186.65%18.6M

123.55%10.46M

142.48%21.1M

200.44%22.63M

Financing cash flow

Cash flow from continuing financing activities

180.41%18.37M

123.19%486K

-115.77%-869K

93.41%-373K

117.38%19.12M

-89.55%6.55M

-293.18%-2.1M

1,911.31%5.51M

-109.56%-5.66M

319.50%8.8M

Net issuance payments of debt

2.09%19.95M

--0

100.00%19.95M

--19.54M

--0

--9.6M

---33K

--9.98M

Proceeds from stock option exercised by employees

-50.61%1.05M

-16.92%486K

--9K

-7.68%553K

-99.89%1K

-55.52%2.12M

-46.08%585K

--0

-54.59%599K

-55.17%940K

Net other financing activities

82.59%-2.63M

--0

78.53%-878K

85.13%-926K

60.91%-828K

-126.11%-15.12M

---2.68M

---4.09M

---6.23M

---2.12M

Cash from discontinued financing activities

Financing cash flow

180.41%18.37M

123.19%486K

-115.77%-869K

93.41%-373K

117.38%19.12M

-89.55%6.55M

-293.18%-2.1M

1,911.31%5.51M

-109.56%-5.66M

319.50%8.8M

Net cash flow

Beginning cash position

29.48%24.46M

52.06%45.41M

79.45%48.81M

63.24%40.29M

29.48%24.46M

-37.81%18.89M

-1.77%29.87M

-67.93%27.2M

23.11%24.68M

-37.81%18.89M

Current changes in cash

49.52%8.33M

-133.55%-12.63M

-227.50%-3.4M

238.10%8.53M

173.38%15.83M

148.50%5.57M

53.04%-5.41M

104.90%2.67M

-96.11%2.52M

156.06%5.79M

End cash Position

34.04%32.79M

52.06%45.41M

79.45%48.81M

63.24%40.29M

29.48%24.46M

-1.77%29.87M

-67.93%27.2M

23.11%24.68M

Free cash flow

72.05%-20.74M

71.61%-6.24M

89.93%-1.36M

146.06%5.93M

26.24%-19.07M

-1,513.22%-74.21M

-15.30%-21.98M

-28.88%-13.49M

-123.49%-12.88M

-29.14%-25.86M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	92.21%-5.74M	71.52%-6.24M	89.78%-1.36M	145.93%5.93M	84.11%-4.07M	-1,354.81%-73.76M	-14.79%-21.91M	-29.17%-13.3M	-123.38%-12.91M	-28.47%-25.64M
Net income from continuing operations	57.16%-25.09M	-47.39%737K	70.10%-5.69M	51.08%-6.6M	50.68%-13.54M	-226.97%-58.57M	106.19%1.4M	9.14%-19.04M	2.38%-13.49M	-169.48%-27.45M
Operating gains losses	292.75%266K	-133.64%-110K	89.62%-22K	--51K	--347K	---138K	--327K	---212K	----	----
Depreciation and amortization	24.05%1.24M	3.17%293K	21.67%292K	24.89%296K	50.63%357K	-14.11%998K	-29.70%284K	-8.05%240K	-8.14%237K	-0.84%237K
Other non cash items	----	----	----	----	----	-78.27%682K	--0	--0	--0	1,036.67%682K
Change In working capital	132.76%9.52M	68.25%-8.83M	-25.64%2.23M	636.95%10.06M	358.65%6.07M	-398.92%-29.05M	-21,467.44%-27.82M	-58.62%2.99M	-102.88%-1.87M	96.25%-2.35M
-Change in receivables	139.32%9.77M	71.75%-7M	-263.00%-2.73M	536.52%8.55M	4,621.55%10.95M	-5,059.68%-24.85M	-5,054.89%-24.8M	-29.74%1.67M	-101.57%-1.96M	100.18%232K
-Change in inventory	149.31%1.17M	227.63%2.53M	132.04%281K	-48.07%309K	-1,640.18%-1.95M	51.24%-2.38M	-540.67%-1.98M	-425.15%-877K	421.93%595K	97.88%-112K
-Change in prepaid assets	335.89%2M	-54.42%-3.25M	9.54%1.95M	96.48%2.9M	119.57%392K	-112.77%-847K	-42.03%-2.1M	164.39%1.78M	-11.35%1.48M	-134.69%-2M
-Change in payables and accrued expense	-302.48%-5.71M	-155.96%-2.79M	308.96%2.7M	27.59%-2.25M	-250.99%-3.37M	-48.82%2.82M	608.97%4.99M	-123.48%-1.29M	-226.34%-3.11M	15.41%2.23M
-Change in other current assets	-86.12%1.13M	-86.96%118K	-101.15%-25K	-94.59%127K	-66.24%905K	0.81%8.11M	-56.53%905K	9.97%2.17M	17.28%2.35M	35.27%2.68M
-Change in other current liabilities	83.41%-2.17M	97.25%-162K	12.98%-2.17M	90.01%-234K	116.90%398K	-51.77%-13.08M	-163.25%-5.89M	-14.17%-2.5M	96.10%-2.34M	-104.22%-2.36M
-Change in other working capital	182.87%3.34M	64.35%1.72M	8.91%2.21M	-41.02%660K	58.23%-1.26M	-53.33%1.18M	-58.34%1.05M	311.89%2.03M	144.44%1.12M	-186.69%-3.02M
Cash from discontinued investing activities
Operating cash flow	92.21%-5.74M	71.52%-6.24M	89.78%-1.36M	145.93%5.93M	84.11%-4.07M	-1,354.81%-73.76M	-14.79%-21.91M	-29.17%-13.3M	-123.38%-12.91M	-28.47%-25.64M
Investing cash flow
Cash flow from continuing investing activities	-105.90%-4.3M	-136.96%-6.87M	-111.19%-1.17M	-85.92%2.97M	-96.57%777K	190.93%72.78M	186.65%18.6M	123.55%10.46M	142.48%21.1M	200.44%22.63M
Net PPE purchase and sale	-41.53%259K	-60.29%110K	-75.56%22K	--0	156.70%127K	170.65%443K	--277K	--90K	--300K	---224K
Net intangibles purchase and sale	---15M	--0	--0	--0	---15M	--0	--0	--0	--0	--0
Net investment purchase and sale	-85.56%10.44M	-138.12%-6.98M	-111.50%-1.19M	-85.72%2.97M	-31.52%15.65M	191.09%72.33M	183.30%18.32M	123.44%10.37M	142.22%20.8M	200.58%22.85M
Cash from discontinued investing activities
Investing cash flow	-105.90%-4.3M	-136.96%-6.87M	-111.19%-1.17M	-85.92%2.97M	-96.57%777K	190.93%72.78M	186.65%18.6M	123.55%10.46M	142.48%21.1M	200.44%22.63M
Financing cash flow
Cash flow from continuing financing activities	180.41%18.37M	123.19%486K	-115.77%-869K	93.41%-373K	117.38%19.12M	-89.55%6.55M	-293.18%-2.1M	1,911.31%5.51M	-109.56%-5.66M	319.50%8.8M
Net issuance payments of debt	2.09%19.95M	--0	--0	--0	100.00%19.95M	--19.54M	--0	--9.6M	---33K	--9.98M
Proceeds from stock option exercised by employees	-50.61%1.05M	-16.92%486K	--9K	-7.68%553K	-99.89%1K	-55.52%2.12M	-46.08%585K	--0	-54.59%599K	-55.17%940K
Net other financing activities	82.59%-2.63M	--0	78.53%-878K	85.13%-926K	60.91%-828K	-126.11%-15.12M	---2.68M	---4.09M	---6.23M	---2.12M
Cash from discontinued financing activities
Financing cash flow	180.41%18.37M	123.19%486K	-115.77%-869K	93.41%-373K	117.38%19.12M	-89.55%6.55M	-293.18%-2.1M	1,911.31%5.51M	-109.56%-5.66M	319.50%8.8M
Net cash flow
Beginning cash position	29.48%24.46M	52.06%45.41M	79.45%48.81M	63.24%40.29M	29.48%24.46M	-37.81%18.89M	-1.77%29.87M	-67.93%27.2M	23.11%24.68M	-37.81%18.89M
Current changes in cash	49.52%8.33M	-133.55%-12.63M	-227.50%-3.4M	238.10%8.53M	173.38%15.83M	148.50%5.57M	53.04%-5.41M	104.90%2.67M	-96.11%2.52M	156.06%5.79M
End cash Position	34.04%32.79M	34.04%32.79M	52.06%45.41M	79.45%48.81M	63.24%40.29M	29.48%24.46M	29.48%24.46M	-1.77%29.87M	-67.93%27.2M	23.11%24.68M
Free cash flow	72.05%-20.74M	71.61%-6.24M	89.93%-1.36M	146.06%5.93M	26.24%-19.07M	-1,513.22%-74.21M	-15.30%-21.98M	-28.88%-13.49M	-123.49%-12.88M	-29.14%-25.86M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall